{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:06:34Z","timestamp":1787731594672,"version":"build-2784847793"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016692","name":"Key Research and Development Program of Ningxia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Bone metastasis, an exceedingly critical and often life - threatening complication in the course of diverse cancer progression, impacts nearly all tumor types, with an especially pronounced prevalence in breast, prostate, lung, liver, and thyroid malignancies. These metastatic lesions are typically localized in the spine, pelvis, shoulders, and distal femur, thereby exerting a substantial influence on patients\u2019 quality of life and prognosis. In numerous instances, the early detection of cancers frequently coincides with patients presenting symptoms induced by bone metastases, which strikingly highlights the severe and debilitating nature of this condition. MicroRNAs (miRNAs), a class of short non - coding RNAs, have emerged as pivotal regulators of gene expression. They are widely and comprehensively acknowledged for their indispensable role in cancer initiation, progression, invasion, and metastasis. Abundant evidence has underscored the involvement of specific miRNAs at various stages of bone metastasis, further emphasizing their vital contribution to the pathogenesis of metastatic bone disease. In this comprehensive review, we systematically collate and summarize the current state - of - the - art knowledge regarding the participation of miRNAs in bone metastasis within breast, prostate, lung, liver, and thyroid cancers. Moreover, we thoroughly explore the potential of miRNAs as therapeutic targets or advanced - generation therapeutic agents for bone metastasis. Concurrently, we also in - depth investigate their function as predictive biomarkers for earlier diagnosis and the development of optimized treatment strategies for cancer patients.<\/jats:p>","DOI":"10.3389\/fonc.2025.1552902","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T07:01:53Z","timestamp":1754377313000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["MicroRNAs in bone metastases: mechanisms and research progression"],"prefix":"10.3389","volume":"15","author":[{"given":"Wei","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZiHan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-018-9461-5","article-title":"Analysis of status and countermeasures of cancer incidence and mortality in China","volume":"62","author":"Wu","year":"2019","journal-title":"Sci China Life Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e10126","DOI":"10.1002\/jbm4.10126","article-title":"Bone as a preferential site for metastasis","volume":"3","author":"Sowder","year":"2019","journal-title":"JBMR Plus"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-017-0378-8","article-title":"Hypoxia and bone metastatic disease","volume":"15","author":"Johnson","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-metastatic niches: organ-specific homes for metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/bs.acr.2016.07.002","article-title":"The relationship between dormant cancer cells and their microenvironment","volume":"132","author":"Linde","year":"2016","journal-title":"Adv Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.02.002","article-title":"Metastatic stem cells: sources, niches, and vital pathways","volume":"14","author":"Oskarsson","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12943-017-0746-0","article-title":"microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11","volume":"17","author":"Cai","year":"2018","journal-title":"Mol Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-021-00677-9","article-title":"MicroRNAs and their roles in breast cancer bone metastasis","volume":"19","author":"Puppo","year":"2021","journal-title":"Curr Osteoporos Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu103","article-title":"Bone health in cancer patients: ESMO Clinical Practice Guidelines","author":"Coleman","year":"2014","journal-title":"Ann Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"CD003474","DOI":"10.1002\/14651858.CD003474.pub4","article-title":"Bisphosphonates and other bone agents for breast cancer","volume":"10","author":"O\u2019Carrigan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu256","article-title":"Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","year":"2014","journal-title":"Ann Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA","volume":"141","author":"Lu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","article-title":"microRNA functions","volume":"23","author":"Bushati","year":"2007","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat Rev Genet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3390\/ijms21051723","article-title":"Regulatory mechanism of microRNA expression in cancer","volume":"21","author":"Ali Syeda","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct Target Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0359","article-title":"OncomiR or tumor suppressor? The duplicity of microRNAs in cancer","volume":"76","author":"Svoronos","year":"2016","journal-title":"Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14836","article-title":"Non-coding RNAs in bone remodelling and bone metastasis: Mechanisms of action and translational relevance","volume":"178","author":"Puppo","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pharmthera.2016.03.003","article-title":"Emerging therapeutic targets in metastatic progression: A focus on breast cancer","volume":"161","author":"Li","year":"2016","journal-title":"Pharmacol Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","article-title":"Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets","volume":"60","author":"Liang","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nature06174","article-title":"Tumour invasion and metastasis initiated by microRNA-10b in breast cancer","volume":"449","author":"Ma","year":"2007","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nature07362","article-title":"MicroRNA-10b and breast cancer metastasis","volume":"455","author":"Gee","year":"2008","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2215","article-title":"TWIST1Expression in breast cancer cells facilitates bone metastasis formation","volume":"29","author":"Croset","year":"2014","journal-title":"J Bone Mineral Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/bcr2720","article-title":"Role of miR-10b in breast cancer metastasis","volume":"12","author":"Ma","year":"2010","journal-title":"Breast Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"40487","DOI":"10.1038\/srep40487","article-title":"Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12593","article-title":"Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells","volume":"7","author":"Taipaleenm\u00e4ki","year":"2016","journal-title":"Oncotarget"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1717363115","article-title":"Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A","volume":"115","author":"Hashimoto","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-3058","article-title":"miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes","volume":"78","author":"Croset","year":"2018","journal-title":"Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2321","article-title":"miR-34a silences c-SRC to attenuate tumor growth in triple-negative breast cancer","volume":"76","author":"Adams","year":"2016","journal-title":"Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190288","article-title":"Risk factors for distant metastasis of patients with primary triple-negative breast cancer","volume":"39","author":"Yao","year":"2019","journal-title":"Biosci Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0288","article-title":"Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study","volume":"17","author":"Finn","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41419-018-0499-8","article-title":"The therapeutic effect of miR-125b is enhanced by the prostaglandin endoperoxide synthase 2\/cyclooxygenase 2 blockade and hampers ETS1 in the context of the microenvironment of bone metastasis","volume":"9","author":"Maroni","year":"2018","journal-title":"Cell Death Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1026","article-title":"Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease","volume":"75","author":"Taipaleenmaki","year":"2015","journal-title":"Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"115139","DOI":"10.1016\/j.bone.2019.115139","article-title":"MicroRNA-429 inhibits bone metastasis in breast cancer by regulating CrkL and MMP-9","volume":"130","author":"Zhang","year":"2020","journal-title":"Bone"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgx141","article-title":"Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities","volume":"39","author":"Tian","year":"2018","journal-title":"Carcinogenesis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a033688","article-title":"Metastases in prostate cancer","volume":"9","author":"Manna","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.job.2019.02.002","article-title":"Bone metastasis: Interaction between cancer cells and bone microenvironment","volume":"61","author":"Hiraga","year":"2019","journal-title":"J Oral Biosci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.3390\/ijms22073528","article-title":"Role of exosomes in prostate cancer metastasis","volume":"22","author":"Akoto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13402-016-0268-6","article-title":"and beyond: alternative prostate cancer biomarkers","volume":"39","author":"Saini S.","year":"2016","journal-title":"Cell Oncol (Dordr)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e12068","DOI":"10.1002\/jev2.12068","article-title":"Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche","volume":"10","author":"Ma","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"B43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12943-017-0688-6","article-title":"Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-kappaB signaling pathway","volume":"16","author":"Ren","year":"2017","journal-title":"Mol Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11708","article-title":"MicroRNAs and epithelial-mesenchymal transition in prostate cancer","volume":"7","author":"Sekhon","year":"2016","journal-title":"Oncotarget"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-23730-5_7","article-title":"microRNAs and prostate cancer","volume":"889","author":"Josson","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-018-1461-z","article-title":"Treating metastatic prostate cancer with microRNA-145","volume":"23","author":"Iscaife","year":"2018","journal-title":"Apoptosis"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.900","article-title":"LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a","volume":"5","author":"Liu","year":"2016","journal-title":"Cancer Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.176","article-title":"A microRNA code for prostate cancer metastasis","volume":"35","author":"Bonci","year":"2016","journal-title":"Oncogene"},{"key":"B49","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canlet.2021.11.017","article-title":"Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a\/Nfatc1\/Angptl2 axis for bone metastasis","volume":"526","author":"Wang","year":"2022","journal-title":"Cancer Lett"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3390\/ijms23031285","article-title":"Exosomal miRNAs from prostate cancer impair osteoblast function in mice","volume":"23","author":"Furesi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29401","article-title":"miR-181b\/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation","volume":"121","author":"Han","year":"2020","journal-title":"J Cell Biochem"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246202","article-title":"Loss of microRNA-135b enhances bone metastasis in prostate cancer and predicts aggressiveness in human prostate samples","volume":"13","author":"Olivan","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.13624","article-title":"Transcriptional downregulation of miR-127-3p by CTCF promotes prostate cancer bone metastasis by targeting PSMB5","volume":"594","author":"Fan","year":"2020","journal-title":"FEBS Lett"},{"key":"B54","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-017-0645-7","article-title":"Downregulation of miR-141-3p promotes bone metastasis via activating NF-kappaB signaling in prostate cancer","volume":"36","author":"Huang","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13046-018-0813-4","article-title":"Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K\/AKT signaling","volume":"37","author":"Tang","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e2572","DOI":"10.1038\/cddis.2017.15","article-title":"MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2","volume":"8","author":"Colden","year":"2017","journal-title":"Cell Death Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","article-title":"Lung cancer 2020: epidemiology, etiology, and prevention","volume":"41","author":"Bade","year":"2020","journal-title":"Clin Chest Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/resp.13870","article-title":"Radiotherapy treatment for lung cancer: Current status and future directions","author":"Vinod","year":"2020","journal-title":"Respirology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2018.12.006","article-title":"Lung cancer","volume":"103","author":"Nasim","year":"2019","journal-title":"Med Clin North Am"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.692788","article-title":"Predictive and prognostic biomarkers for lung cancer bone metastasis and their therapeutic value","volume":"11","author":"Chai","year":"2021","journal-title":"Front Oncol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-019-0959-5","article-title":"Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41419-021-03928-w","article-title":"Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p\/RAC1 signalling axis in osteoclasts","volume":"12","author":"Ni","year":"2021","journal-title":"Cell Death Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/s41419-021-04324-0","article-title":"MicroRNA-106a regulates autophagy-related cell death and EMT by targeting TP53INP1 in lung cancer with bone metastasis","volume":"12","author":"Han","year":"2021","journal-title":"Cell Death Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2018.05.008","article-title":"Lung adenocarcinoma cell-derived exosomal miR-21 facilitates osteoclastogenesis","volume":"666","author":"Xu","year":"2018","journal-title":"Gene"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S232876","article-title":"Lung Cancer Cells Derived Circulating miR-21 Promotes Differentiation of Monocytes into Osteoclasts","volume":"13","author":"Zhao","year":"2020","journal-title":"Onco Targets Ther"},{"key":"B67","doi-asserted-by":"publisher","first-page":"112834","DOI":"10.1016\/j.yexcr.2021.112834","article-title":"Non-small cell lung cancer cell-derived exosomal miR-17-5p promotes osteoclast differentiation by targeting PTEN","volume":"408","author":"Wang","year":"2021","journal-title":"Exp Cell Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"19619","DOI":"10.1038\/s41598-019-56018-5","article-title":"miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44","volume":"9","author":"Zou","year":"2019","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","article-title":"Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Mechanisms and Therapy of Liver Cancer","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv Cancer Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.3390\/ijms22094997","article-title":"Exosomal microRNAs as biomarkers and therapeutic targets for hepatocellular carcinoma","volume":"22","author":"Sorop","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12943-019-1044-9","article-title":"The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol Cancer"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13531","article-title":"MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma","volume":"7","author":"Xiang","year":"2016","journal-title":"Oncotarget"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2019.03.028","article-title":"MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29","volume":"224","author":"Du","year":"2019","journal-title":"Life Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2015.05.010","article-title":"MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration","volume":"73","author":"Li","year":"2015","journal-title":"BioMed Pharmacother"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2015.2379","article-title":"Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells","volume":"36","author":"Wu","year":"2015","journal-title":"Int J Mol Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.02.118","article-title":"The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells","volume":"101","author":"Ma","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B78","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-017-0675-y","article-title":"MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K\/AKT pathway","volume":"16","author":"Xu","year":"2017","journal-title":"Mol Cancer"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00027-9","article-title":"Thyroid cancer incidence trends by histology in 25 countries: a population-based study","volume":"9","author":"Miranda-Filho","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31884","article-title":"Thyroid cancer \u201cepidemic\u201d also occurs in low- and middle-income countries","volume":"144","author":"Lortet-Tieulent","year":"2019","journal-title":"Int J Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0684","article-title":"Long-term declines of thyroid cancer mortality: an international age-period-cohort analysis","volume":"30","author":"Li","year":"2020","journal-title":"Thyroid"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33690","article-title":"Thyroid cancer, recent advances in diagnosis and therapy","volume":"149","author":"Nabhan","year":"2021","journal-title":"Int J Cancer"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3892\/or_00001007","article-title":"Anthocyanins are novel AMPK\u03b11 stimulators that suppress tumor growth by inhibiting mTOR phosphorylation","volume":"24","year":"2010","journal-title":"Oncol Rep"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6739","article-title":"MicroRNA\u2212mRNA integrated analysis based on a case of well\u2212differentiated thyroid cancer with both metastasis and metastatic recurrence","volume":"40","author":"Zhang","year":"2018","journal-title":"Oncol Rep"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S117338","article-title":"miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial-mesenchymal transition","volume":"9","author":"Zhang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16498","article-title":"Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma","volume":"8","author":"Fujiwara","year":"2017","journal-title":"Oncotarget"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4086-7","article-title":"MiR-30a regulates the proliferation, migration, and invasion of human osteosarcoma by targeting Runx2","volume":"37","author":"Zhang","year":"2016","journal-title":"Tumour Biol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.4718","article-title":"MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma","volume":"35","author":"Ma","year":"2016","journal-title":"Oncol Rep"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3892\/or.2015.4393","article-title":"miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3","volume":"35","author":"Xu","year":"2016","journal-title":"Oncol Rep"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-017-0374-4","article-title":"ROCK1-predictedmicroRNAs dysregulation contributes to tumor progression in ewing sarcoma","volume":"26","author":"Roberto","year":"2020","journal-title":"Pathol Oncol Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1552902\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T07:01:54Z","timestamp":1754377314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1552902\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":90,"alternative-id":["10.3389\/fonc.2025.1552902"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1552902","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"article-number":"1552902"}}